Lee Financial’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-397
| Closed | -$207K | – | 181 |
|
2024
Q4 | $207K | Sell |
397
-30
| -7% | -$15.6K | 0.03% | 171 |
|
2024
Q3 | $264K | Buy |
+427
| New | +$264K | 0.04% | 157 |
|
2024
Q1 | – | Sell |
-19
| Closed | -$10.1K | – | 754 |
|
2023
Q4 | $10.1K | Buy |
19
+4
| +27% | +$2.13K | ﹤0.01% | 430 |
|
2023
Q3 | $7.6K | Buy |
+15
| New | +$7.6K | ﹤0.01% | 448 |
|
2023
Q1 | – | Sell |
-5
| Closed | -$2.75K | – | 948 |
|
2022
Q4 | $2.75K | Sell |
5
-5
| -50% | -$2.75K | ﹤0.01% | 636 |
|
2022
Q3 | $6K | Buy |
10
+2
| +25% | +$1.2K | ﹤0.01% | 518 |
|
2022
Q2 | $5K | Buy |
+8
| New | +$5K | ﹤0.01% | 566 |
|
2022
Q1 | – | Sell |
-48
| Closed | -$32K | – | 953 |
|
2021
Q4 | $32K | Buy |
+48
| New | +$32K | 0.01% | 303 |
|
2020
Q1 | – | Sell |
-27
| Closed | -$9K | – | 514 |
|
2019
Q4 | $9K | Hold |
27
| – | – | ﹤0.01% | 370 |
|
2019
Q3 | $8K | Hold |
27
| – | – | ﹤0.01% | 386 |
|
2019
Q2 | $8K | Hold |
27
| – | – | ﹤0.01% | 391 |
|
2019
Q1 | $7K | Buy |
+27
| New | +$7K | ﹤0.01% | 393 |
|
2018
Q3 | – | Sell |
-51
| Closed | -$11K | – | 698 |
|
2018
Q2 | $11K | Hold |
51
| – | – | ﹤0.01% | 460 |
|
2018
Q1 | $11K | Buy |
51
+15
| +42% | +$3.24K | ﹤0.01% | 453 |
|
2017
Q4 | $7K | Sell |
36
-67
| -65% | -$13K | ﹤0.01% | 405 |
|
2017
Q3 | $19K | Buy |
103
+85
| +472% | +$15.7K | 0.01% | 251 |
|
2017
Q2 | $3K | Buy |
+18
| New | +$3K | ﹤0.01% | 449 |
|
2017
Q1 | – | Sell |
-93
| Closed | -$13K | – | 430 |
|
2016
Q4 | $13K | Buy |
+93
| New | +$13K | 0.01% | 257 |
|